EFFECT OF AQUEOUS EXTRACT TERMINALIA CATTAPA LEAF ON LIVER SOD, CATALASE AND MDA IN CYCLOPHOSPAHAMIDE INDUCED IMMUNOCOMPROMIED WISTAR RATS

Student: Marita Ayibam Ntol
Supervisor: Dr Dasofunjo Kayode
HOD: Dr Ujong Peter
Department of Medical Biochemistry
Basic Medical Sciences
University of Cross River State, Calabar

Abstract

Terminalia catappa is a medicinal plant with wide application in African traditional medicine for | the management of several pathological conditions. This present research work was designed to evaluate... The experimental rats were randomly divided into five (5) groups, with five animals per group and treated for a period of fourteen (14) days. Group A: NC (normal control) Group C: immune compromised rats treated with immunal (Standard control) Group B: immune compromised rats (induced with cyclophosphamide) without treatment (immune compromised control) Group D: immune compromised rats treated with 100mg/kg bwt aqueous leaf extract T. catappa extract (ALETCI) Group E: immune compromised rats with 200mg/kg bwt aqueous leaf extract T. catappa extract (ALETC2) All administrations were done orally using orpharyngeal cannula once per day for 14 days (2 week). The extracts of Terminalia catappa significantly lowered liver SOD, Catalase and MDA concentration at 200 and 400 mg/kg body weight when compared with the normal and standard control. This suggests that extracts possess the potential for reversing possible tissue oxidative damage caused by cyclophoamide as seen by their abilities to prevent lipid peroxidation.

Full-Text Access Notice

In accordance with the NERD Policy on promoting peer-reviewed publication, public access to the full text of a project, thesis or dissertation is restricted for three years, allowing the author and supervisors sufficient time to pursue peer-reviewed publication. During this period, researchers with legitimate academic or research purposes may request authorisation directly from the author to enable NERD to release the indexed full texts of the work using the form below.

Request authorisation from the author